(Q52620379)

English

Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumors.

scientific article published on 10 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumors. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

pharmacokinetics

1 reference

based on heuristic

inferred from title

Anwar R Padhani

12

object named as

Anwar R Padhani

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

author name string

Dan M Patterson

1

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

Martin Zweifel

2

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

Mark R Middleton

3

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

Patricia M Price

4

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

Lisa K Folkes

5

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

Michael R L Stratford

6

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

Phil Ross

7

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

Sarah Halford

8

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

Jane Peters

9

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

Jai Balkissoon

10

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

Dai J Chaplin

11

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

Gordon J S Rustin

13

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

language of work or name

0 references

publication date

10 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

Clinical Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

18

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

5

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

1415-1425

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

Identifiers

10.1158/1078-0432.CCR-11-2414

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/22235096

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52620379&oldid=2143381253"